NLRP12/C1qA positive feedback in tumor-associated macrophages regulates immunosuppression through LILRB4/NF-κB pathway in lung adenocarcinoma
Cancer Immunology, Immunotherapy · 11.11.2024 · 74 (1)
DOI: 10.1007/s00262-024-03880-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, online erschienen am 11.11.2024. Verfasst von Jiaxin Yin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Center, Renmin Hospital of Wuhan University, Wuhan, China. Hauptthemen laut MEDLINE: NF-kappa B, Adenocarcinoma of Lung, Receptors, Immunologic, Lung Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Science and Technology Research and Development Project Fund of Xiangyang, National Natural Science Foundation of China, Beijing Xisike Clinical Oncology Research Foundation.
Abstract (Originalsprache)
The anti-tumor immune response is greatly hindered by the protumor polarization of tumor-associated macrophages (TAMs). Cancer-related inflammation plays a central role in TAMs protumor polarization. Our study explored the unique positive feedback loop between inflammasome and complement in TAMs. The present study identified NOD-like receptors family pyrin domain containing 12 (NLRP12) formed positive feedback with C1qA and drove TAMs protumor polarization via the LILRB4/NF-κB pathway. In addition, NLRP12 was predominantly expressed in TAMs and was associated with poorer prognosis in lung adenocarcinoma (LUAD) patients. Knocking down LILRB4 inhibited TAMs protumor polarization. NLRP12-overexpressing TAMs promoted tumor cells' malignant progression and inhibited T cells' proliferation and cytotoxic function. Lastly, NLRP12 knockout (NLRP12-/-) reversed macrophage polarization, enhanced T-cell anti-tumor immunity, and suppressed tumor growth. Our findings highlighted the essential role of NLRP12/C1qA positive feedback loop and the LILRB4/NF-κB pathway in promoting TAMs protumor polarization. Inhibition of NLRP12 suppressed tumor development and promoted immune response. NLRP12 may be a promising target for LUAD immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Center, Renmin Hospital of Wuhan University, Wuhan, China.
- Department of Oncology, Xiangyang Hospital, Hubei University of Chinese Medicine, Xiangyang, China.
- Department of Oncology, The First Affiliated Hospital of Shandong First Medical University, Jinan, China.
- Department of Thoracic Surgery, Renmin Hospital of Wuhan University, Wuhan, China.
- Cancer Center, Renmin Hospital of Wuhan University, Wuhan, China. bichengzhang@hotmail.com.
Förderung
- Science and Technology Research and Development Project Fund of Xiangyang
- National Natural Science Foundation of China
- Beijing Xisike Clinical Oncology Research Foundation
- Wuhan Municipal Science and Technology Bureau
Zitieren
APA
Yin, J., Song, Y., Fu, Y., Wang, J., Zhang, Z., Ruan, S., Liu, G., & Zhang, B. (2024). NLRP12/C1qA positive feedback in tumor-associated macrophages regulates immunosuppression through LILRB4/NF-κB pathway in lung adenocarcinoma. Cancer Immunology, Immunotherapy, 74(1). https://doi.org/10.1007/s00262-024-03880-6
Vancouver
Yin J, Song Y, Fu Y, Wang J, Zhang Z, Ruan S, et al. NLRP12/C1qA positive feedback in tumor-associated macrophages regulates immunosuppression through LILRB4/NF-κB pathway in lung adenocarcinoma. Cancer Immunology, Immunotherapy. 2024;74(1). doi:10.1007/s00262-024-03880-6
BibTeX
@article{Yin2024,
author = {Yin, Jiaxin and Song, Yuxiao and Fu, Yang and Wang, Jun and Zhang, Zhimin and Ruan, Shasha and Liu, Gaoli and Zhang, Bicheng},
title = {NLRP12/C1qA positive feedback in tumor-associated macrophages regulates immunosuppression through LILRB4/NF-κB pathway in lung adenocarcinoma},
journal = {Cancer Immunology, Immunotherapy},
year = {2024},
volume = {74},
number = {1},
doi = {10.1007/s00262-024-03880-6}
}
EUVIMED